{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T01:50:04Z","timestamp":1789609804461,"version":"build-2803163510"},"reference-count":47,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,12,8]],"date-time":"2021-12-08T00:00:00Z","timestamp":1638921600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82072768, 81802994"],"award-info":[{"award-number":["82072768, 81802994"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Gliomas with chromosome 1p\/19q codeletion were considered a specific tumor entity. This study was designed to reveal the biological function alterations tightly associated with 1p\/19q codeletion in gliomas. Clinicopathological and RNA sequencing data from glioma patients were obtained from The Cancer Genome Atlas and Chinese Glioma Genome Atlas databases. Gene set variation analysis was performed to explore the differences in biological functions between glioma subgroups stratified by 1p\/19q codeletion status. The abundance of immune cells in each sample was detected using the CIBERSORT analytical tool. Single-cell sequencing data from public databases were analyzed using the t-distributed stochastic neighbor embedding (t-SNE) algorithm, and the findings were verified by <jats:italic>in vitro<\/jats:italic> and <jats:italic>in vivo<\/jats:italic> experiments and patient samples.We found that the activation of immune and inflammatory responses was tightly associated with 1p\/19q codeletion in gliomas. As the most important transcriptional regulator of Galectin-9 in gliomas, the expression level of CCAAT enhancer-binding protein alpha in samples with 1p\/19q codeletion was significantly decreased, which led to the downregulation of the immune checkpoints Galectin-9 and TIM-3. These results were validated in three independent datasets. The t-SNE analysis showed that the loss of chromosome 19q was the main reason for the promotion of the antitumor immune response. IHC protein staining, <jats:italic>in vitro<\/jats:italic> and <jats:italic>in vivo<\/jats:italic> experiments verified the results of bioinformatics analysis. In gliomas, 1p\/19q codeletion can promote the antitumor immune response by downregulating the expression levels of the immune checkpoint TIM-3 and its ligand Galectin-9.<\/jats:p>","DOI":"10.3389\/fimmu.2021.800928","type":"journal-article","created":{"date-parts":[[2021,12,8]],"date-time":"2021-12-08T05:14:11Z","timestamp":1638940451000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["Galectin-9\/TIM-3 as a Key Regulator of Immune Response in Gliomas With Chromosome 1p\/19q Codeletion"],"prefix":"10.3389","volume":"12","author":[{"given":"Guanzhang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruoyu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhua","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingchen","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanhao","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changqing","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,12,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2016.01.024","article-title":"CGCG Clinical Practice Guidelines for the Management of Adult Diffuse Gliomas","volume":"375","author":"Jiang","year":"2016","journal-title":"Cancer Lett"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(11)61346-9","article-title":"Primary Brain Tumours in Adults","volume":"379","author":"Ricard","year":"2012","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","first-page":"iv1","DOI":"10.1093\/neuonc\/nou223","article-title":"CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2007-2011","volume":"16","author":"Ostrom","year":"2014","journal-title":"Neuro Oncol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0808710","article-title":"IDH1 and IDH2 Mutations in Gliomas","volume":"360","author":"Yan","year":"2009","journal-title":"N Engl J Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/not299","article-title":"Analysis of IDH Mutation, 1p\/19q Deletion, and PTEN Loss Delineates Prognosis in Clinical Low-Grade Diffuse Gliomas","volume":"16","author":"Sabha","year":"2014","journal-title":"Neuro Oncol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/nou138","article-title":"Assessing CpG Island Methylator Phenotype, 1p\/19q Codeletion, and MGMT Promoter Methylation From Epigenome-Wide Data in the Biomarker Cohort of the NOA-04 Trial","volume":"16","author":"Wiestler","year":"2014","journal-title":"Neuro Oncol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016 World Health Organization Classification of Tumors of the Central Nervous System: A Summary","volume":"131","author":"Louis","year":"2016","journal-title":"Acta Neuropathol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1407279","article-title":"Glioma Groups Based on 1p\/19q, IDH, and TERT Promoter Mutations in Tumors","volume":"372","author":"Eckel-Passow","year":"2015","journal-title":"N Engl J Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1097\/01.MP.0000076981.90281.BF","article-title":"Fluorescent In Situ Hybridization on Isolated Tumor Cell Nuclei: A Sensitive Method for 1p and 19q Deletion Analysis in Paraffin-Embedded Oligodendroglial Tumor Specimens","volume":"16","author":"Gelpi","year":"2003","journal-title":"Mod Pathol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.2217\/cns.15.32","article-title":"Molecular Background of Oligodendroglioma: 1p\/19q, IDH, TERT, CIC and FUBP1","volume":"4","author":"Cahill","year":"2015","journal-title":"CNS Oncol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-017-0519-x","article-title":"Glioma Subclassifications and Their Clinical Significance","volume":"14","author":"Chen","year":"2017","journal-title":"Neurotherapeutics"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/nos065","article-title":"Initial Treatment Patterns Over Time for Anaplastic Oligodendroglial Tumors","volume":"14","author":"Panageas","year":"2012","journal-title":"Neuro Oncol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgz102","article-title":"Systematically Characterize the Clinical and Biological Significances of 1p19q Genes in 1p\/19q Non-Codeletion Glioma","volume":"40","author":"Chai","year":"2019","journal-title":"Carcinogenesis"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1089\/omi.2020.0019","article-title":"Taking a Full Snapshot of Cancer Biology: Deciphering the Tumor Microenvironment for Effective Cancer Therapy in the Oncology Clinic","volume":"24","author":"Dzobo","year":"2020","journal-title":"OMICS"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: Gene Set Variation Analysis for Microarray and RNA-Seq Data","volume":"14","author":"Hanzelmann","year":"2013","journal-title":"BMC Bioinf"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.3337","article-title":"Robust Enumeration of Cell Subsets From Tissue Expression Profiles","volume":"12","author":"Newman","year":"2015","journal-title":"Nat Methods"},{"key":"B17","doi-asserted-by":"publisher","first-page":"R15","DOI":"10.1186\/bcr2234","article-title":"T-Cell Metagene Predicts a Favorable Prognosis in Estrogen Receptor-Negative and HER2-Positive Breast Cancers","volume":"11","author":"Rody","year":"2009","journal-title":"Breast Cancer Res"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e1328339","DOI":"10.1080\/2162402X.2017.1328339","article-title":"Molecular and Clinical\u00a0Characterization of TIM-3 in Glioma Through 1,024 Samples","volume":"6","author":"Li","year":"2017","journal-title":"Oncoimmunology"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3892\/or.2018.6611","article-title":"CKAP2 Expression Is Associated With Glioma Tumor Growth and Acts as a Prognostic Factor in Highgrade Glioma","volume":"40","author":"Wang","year":"2018","journal-title":"Oncol Rep"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e1196310","DOI":"10.1080\/2162402X.2016.1196310","article-title":"Molecular and Clinical Characterization of PD-L1 Expression at Transcriptional Level via 976 Samples of Brain Glioma","volume":"5","author":"Wang","year":"2016","journal-title":"Oncoimmunology"},{"key":"B21","article-title":"Use of a Monoclonal Anti-Estrogen Receptor Antibody in the Immunohistochemical Evaluation of Human Tumors","volume":"46","author":"McCarty","year":"1986","journal-title":"Cancer Res"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-018-0212-z","article-title":"TanCAR T Cells Targeting CD19 and CD133 Efficiently Eliminate MLL Leukemic Cells","volume":"32","author":"Li","year":"2018","journal-title":"Leukemia"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1038\/s41419-018-1232-3","article-title":"ALDH1A3 Induces Mesenchymal Differentiation and Serves as a Predictor for Survival in Glioblastoma","volume":"9","author":"Li","year":"2018","journal-title":"Cell Death Dis"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1043\/1543-2165(2007)131[242:CAOQLA]2.0.CO;2","article-title":"Clinicopathologic Aspects of 1p\/19q Loss and the Diagnosis of Oligodendroglioma","volume":"131","author":"Aldape","year":"2007","journal-title":"Arch Pathol Lab Med"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1093\/neuros\/nyz333","article-title":"The Relationship Between Tumor-Stroma Ratio, the Immune Microenvironment, and Survival in Patients With Spinal Chordoma","volume":"85","author":"Zou","year":"2019","journal-title":"Neurosurgery"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/emboj.2011.151","article-title":"AP-2gamma Regulates Oestrogen Receptor-Mediated Long-Range Chromatin Interaction and Gene Transcription","volume":"30","author":"Tan","year":"2011","journal-title":"EMBO J"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-12-152","article-title":"Cross Species Comparison of C\/EBPalpha and PPARgamma Profiles in Mouse and Human Adipocytes Reveals Interdependent Retention of Binding Sites","volume":"12","author":"Schmidt","year":"2011","journal-title":"BMC Genomics"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-14-1030","article-title":"CtBP2 Modulates the Androgen Receptor to Promote Prostate Cancer Progression","volume":"74","author":"Takayama","year":"2014","journal-title":"Cancer Res"},{"key":"B29","article-title":"CAR-Armed Cell Therapy for Gliomas","volume":"9","author":"Zhai","year":"2019","journal-title":"Am J Cancer Res"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aau8943","article-title":"RIG-I Activation Is Critical for Responsiveness to Checkpoint Blockade","volume":"4","author":"Heidegger","year":"2019","journal-title":"Sci Immunol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-019-0433-y","article-title":"Mechanisms of Immunotherapy Resistance: Lessons From Glioblastoma","volume":"20","author":"Jackson","year":"2019","journal-title":"Nat Immunol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ccell.2017.06.003","article-title":"Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates With Immunological Changes in the Microenvironment","volume":"32","author":"Wang","year":"2017","journal-title":"Cancer Cell"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3322\/caac.20069","article-title":"Exciting New Advances in Neuro-Oncology: The Avenue to a Cure for Malignant Glioma","volume":"60","author":"Van Meir","year":"2010","journal-title":"CA Cancer J Clin"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.5683","article-title":"IDH Mutation and MGMT Promoter Methylation in Glioblastoma: Results of a Prospective Registry","volume":"6","author":"Yang","year":"2015","journal-title":"Oncotarget"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/90.19.1473","article-title":"Specific Genetic Predictors of Chemotherapeutic Response and Survival in Patients With Anaplastic Oligodendrogliomas","volume":"90","author":"Cairncross","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1093\/neuros\/nyz072","article-title":"Optimizing Postoperative Surveillance of Pediatric Low-Grade Glioma Using Tumor Behavior Patterns","volume":"86","author":"Zaazoue","year":"2020","journal-title":"Neurosurgery"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-017-1690-1","article-title":"Adult Infiltrating Gliomas With WHO 2016 Integrated Diagnosis: Additional Prognostic Roles of ATRX and TERT","volume":"133","author":"Pekmezci","year":"2017","journal-title":"Acta Neuropathol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S223406","article-title":"Siglecs, Novel Immunotherapy Targets, Potentially Enhance The Effectiveness of Existing Immune Checkpoint Inhibitors in Glioma Immunotherapy","volume":"12","author":"Li","year":"2019","journal-title":"Onco Targets Ther"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1093\/neuros\/nyaa025","article-title":"Avoiding New Biopsies by Identification of IDH1 and TERT Promoter Mutation in Nondiagnostic Biopsies From Glioma Patients","author":"Barritault","year":"2020","journal-title":"Neurosurgery"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1097\/PPO.0b013e31818d8178","article-title":"Gliomas With 1p\/19q Codeletion: a.K.a. Oligodendroglioma","volume":"14","author":"Cairncross","year":"2008","journal-title":"Cancer J"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1500925","article-title":"Radiation Plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma","volume":"374","author":"Buckner","year":"2016","journal-title":"N Engl J Med"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2012.12.024","article-title":"Understanding High Grade Glioma: Molecular Mechanism, Therapy and Comprehensive Management","volume":"331","author":"Wang","year":"2013","journal-title":"Cancer Lett"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A5572","article-title":"MRI Features Can Predict 1p\/19q Status in Intracranial Gliomas","volume":"39","author":"Lasocki","year":"2018","journal-title":"AJNR Am J Neuroradiol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1038\/nature16071","article-title":"Brain Tumour Cells Interconnect to a Functional and Resistant Network","volume":"528","author":"Osswald","year":"2015","journal-title":"Nature"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2017.1303582","article-title":"Immune Infiltration of Tumor Microenvironment Following Immunotherapy for Glioblastoma Multiforme","volume":"13","author":"Sokratous","year":"2017","journal-title":"Hum Vaccin Immunother"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2016.01.043","article-title":"Tumor Microenvironment and Therapeutic Response","volume":"387","author":"Wu","year":"2017","journal-title":"Cancer Lett"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-019-0149-1","article-title":"Ferroptosis at the Crossroads of Cancer-Acquired Drug Resistance and Immune Evasion","volume":"19","author":"Friedmann Angeli","year":"2019","journal-title":"Nat Rev Cancer"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.800928\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,8]],"date-time":"2021-12-08T05:14:14Z","timestamp":1638940454000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.800928\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,8]]},"references-count":47,"alternative-id":["10.3389\/fimmu.2021.800928"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.800928","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,8]]},"article-number":"800928"}}